Special needs of the adolescent with epilepsy

Epilepsia

Volumn 42, Issue SUPPL. 6, 2001, Pages 10-17

  Nordli D R , Jr ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Antiepileptic drug interactions; Antiepileptic drug side effects; Epilepsy, psychosocial; Juvenile absence epilepsy; Juvenile myoclonic epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ARTICLE; CHILD HEALTH CARE; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; EDUCATION; EPILEPSY; GINGIVA HYPERPLASIA; HAIR LOSS; HUMAN; HYPONATREMIA; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; QUESTIONNAIRE; SELF CONTROL; SELF ESTEEM; SOCIAL SUPPORT; TERATOGENICITY; WEIGHT GAIN;

EID: 0035215880     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.42.s8.6.x     Document Type: Article

References (46)

1. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984
2. Lamotrigine in typical absence epilepsy
3. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy
4. Lamotrigine in absence and primary generalized epilepsies
5. Lamotrigine in childhood epilepsies
6. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: A video-EEG-controlled, open study
7. Topiramate for drug-resistant epilepsies
8. Topiramate in intractable childhood onset epilepsy: A cautionary note
9. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome: Topiramate YL Study Group
10. Topiramate: Clinical profile in epilepsy
11. Preliminary observations on topiramate in pediatric epilepsies
12. Zonisamide monotherapy against absence attacks: Report of two cases
13. The antiepileptic effect of zonisamide on patients with refractory seizures and its side effect
14. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy
15. Evidence for linkage of adolescentonset idiopathic generalized epilepsies to chromosome 8 and genetic heterogeneity
16. Replication analysis of a putative susceptibility locus (EGI) for idiopathic generalized epilepsy on chromosome 8q24
17. Juvenile myoclonic epilepsy in chromosome 6p12-p11: Locus heterogeneity and recombinations
18. Reproducibility and complications in gene searches: Linkage on chromosome 6, heterogeneity, association, and maternal inheritance in juvenile myoclonic epilepsy
19. No evidence for a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q
20. Juvenile myoclonic epilepsy: Longterm response to therapy
21. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?
22. Polycystic ovary syndrome in patients with focal epilepsy: A study in 93 women
23. Valproate, hyperandrogenism, and polycystic ovaries: A report of 3 cases
24. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy
25. Obesity and endocrine disorders in women taking valproate for epilepsy
26. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy
27. Maternal use of antiepileptic drugs and the risk of major congenital malformations: A joint European prospective study of human teratogenesis associated with maternal epilepsy
28. The use of lamotrigine in juvenile myoclonic epilepsy
29. Exacerbation of juvenile myoclonic epilepsy with lamotrigine
30. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures
31. Hyponatremia induced by oxcarbazepine
32. Long-term prognosis of seizures with onset in childhood
33. How often is medication taken as prescribed? A novel assessment technique
34. Compliance with anticonvulsant therapy by epileptic youth: Relationships to psychosocial aspects of adolescent development
35. Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children
36. Risk of excessive weight gain in epileptic children treated with valproate
37. Phenytoin-induced gingival overgrowth: A community-based cross-sectional study in Ferrara, Italy
38. Hair loss in psychopharmacology
39. Quality of life in children with well-controlled epilepsy
40. Antiepileptic drug-related cognitive complaints in seizure-free children with epilepsy before and after drug discontinuation
41. Consensus statements: Medical management of epilepsy
42. The role of serotonin(2) receptors in mediating cocaine-induced convulsions
43. Illicit drug use and the risk of new-onset seizures
44. Possibilities of non-pharmacological conservative treatment of epilepsy
45. Primary (idiopathic) generalized epilepsy and underlying mechanisms